Clinical Research On Jia Wei Bu Yang Huan Wu Decoction In Treatment Of Acute Cerebral Infarction

ObjectiveModified Bu Yang Huan Wu Tang (BYHWD) observed treatment of acute cerebral infarction (ischemic stroke Qi and Blood) the premise of the efficacy and thrombosis before and after the change of protein for the Modified BYHWD treatment of acute cerebral infarction (ischemic stroke Qi and Blood) provides the basis for the clinical aspects.Methods60 cases met the inclusion criteria were randomly divided into 2 groups. Treatment group and control group were 30 cases. Aspirin tablets are 100mg, simvastatin capsules 20mg, once each day, oral; dredge cycle, nutrition nerve; acupuncture and physical functional rehabilitation exercise. Treatment group: In the control group, based on the Buyanghuanwu Tonga Scorpion, Centipede, based on tripartite and other Loranthaceae Modified BYHWD, (Chinese Medicine Hospital of Guangdong Province, Xinhui prescription Agreement:I side hemiplegia), water After the re-fried decoction twice a day, each 200ml,3 times a day, orally. Observed in each group and treatment group were enrolled in each group after 7 days of thrombus precursor protein (TpP) and changes in coagulation, two groups of patients before treatment and weekly symptoms and efficacy of traditional Chinese medicine, physical changes in neurological deficit, etc., Modified by systematic reviews BYHWD the clinical efficacy of the treatment of acute cerebral infarction. All data were analysised by SPSS17.0. Results were expressed as mean±standard deviation, t test were used to evaluation.Results1. General Information:Two patients in gender, age, neurological deficit score, TCM symptom score, complications, etc. In general no significant difference (P>0.05). 2.55 cases are put into our research practically, and 5 cases fell off in the 60 cases. So 27 cases in treatment group and control group in 28 cases practically. The total effective rate of 92.6% in treatment group and control group was 82.1% in both groups, the difference was significant (P<0.05), the treatment group than the control group. Before treatment,7d after the thrombus precursor protein (TpP) coagulation indices and the comparison group prothrombin time, thrombin time, partial thromboplastin time, fibrinogen than the control group were reduced, statistical analysis Results:p<0.05 was considered statistically significant.3. Before treatment,7d after the two groups of neurological deficit scores were significantly reduced compared with before treatment, the differences were significant (P<0.05), after treatment, the treatment group score lower than the control group, the difference was significant significance (P<0.05).ConclusionThis clinical study of acute cerebral infarction (ischemic stroke Qi and Blood) patients as the research object, from the thrombus precursor protein (TpP) and coagulation, neurological deficit, and other aspects of clinical observation to understand Modified BYHWD improve the neurological deficit and improving the role of clinical efficacy. Compared with the control group, using the Modified BYHWD treatment of acute cerebral infarction (ischemic stroke Qi and Blood) and the clinical effect is significant.